Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma: Phase I Portion
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis
- Status
- COMPLETED
- Phase
- NA
Comparative Study of Individualized Sensitivity-Directed Chemotherapy Versus DTIC
- Status
- UNKNOWN
- Phase
- PHASE3
Feasibility and Functionality of fPAM Imaging in Melanoma
- Status
- TERMINATED
- Phase
- N/A
Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
The Impact of Total Body Skin Examination on Skin Cancer Detection
- Status
- COMPLETED
- Phase
- NA
A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of High-dose Interferon Alfa-2b (Intron A®) for the Adjuvant Treatment of Malignant Melanoma (Study P04083)
- Status
- COMPLETED
- Phase
- N/A
A Phase II Study of an Anti-Tumor Immunotherapy Regimen Comprised of Pegylated Interferon-Alpha 2b and HyperAcute Melanoma Vaccine for Subjects With Advanced Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
Illness Related Distress in Women With Clinically Localized Cutaneous Melanoma
- Status
- COMPLETED
- Phase
- N/A
A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
IDO Inhibitor Study for Relapsed or Refractory Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Efficacy Study of TLN-232 in Patients With Recurring Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Effect of Proactive Management of Side Effects on Treatment Compliance in Malignant Melanoma Patients on High-dose Intron A Therapy (Study P04600)
- Status
- COMPLETED
- Phase
- N/A
Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2